Growth Metrics

Acadia Healthcare Company (ACHC) Return on Sales (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Return on Sales for 17 consecutive years, with 0.01% as the latest value for Q1 2026.

  • For Q1 2026, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM value through Mar 2026 reached 0.32%, down 39.0%, while the annual FY2025 figure was 0.33%, 41.0% down from the prior year.
  • Return on Sales hit 0.01% in Q1 2026 for Acadia Healthcare Company, up from 1.43% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.13% in Q2 2022 and bottomed at 1.43% in Q4 2025.
  • Average Return on Sales over 5 years is 0.03%, with a median of 0.09% recorded in 2024.
  • Year-over-year, Return on Sales surged 50bps in 2022 and then plummeted -148bps in 2025.
  • Acadia Healthcare Company's Return on Sales stood at 0.09% in 2022, then fell by -14bps to 0.08% in 2023, then tumbled by -46bps to 0.04% in 2024, then tumbled by -3407bps to 1.43% in 2025, then skyrocketed by 100bps to 0.01% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.01%, 1.43%, and 0.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.